356 related articles for article (PubMed ID: 21254067)
1. Sustained-release and swelling characteristics of xanthan gum/ethylcellulose-based injection moulded matrix tablets: in vitro and in vivo evaluation.
Quinten T; De Beer T; Onofre FO; Mendez-Montealvo G; Wang YJ; Remon JP; Vervaet C
J Pharm Sci; 2011 Jul; 100(7):2858-70. PubMed ID: 21254067
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
Quinten T; De Beer T; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide.
Quinten T; De Beer T; Almeida A; Vlassenbroeck J; Van Hoorebeke L; Remon JP; Vervaet C
Drug Dev Ind Pharm; 2011 Feb; 37(2):149-59. PubMed ID: 20615154
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation and process parameters on the release characteristics of ethylcellulose sustained-release mini-matrices produced by hot-melt extrusion.
Verhoeven E; De Beer TR; Van den Mooter G; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2008 May; 69(1):312-9. PubMed ID: 18036793
[TBL] [Abstract][Full Text] [Related]
5. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
Quinten T; Andrews GP; De Beer T; Saerens L; Bouquet W; Jones DS; Hornsby P; Remon JP; Vervaet C
AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
[TBL] [Abstract][Full Text] [Related]
7. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
8. Xanthan gum to tailor drug release of sustained-release ethylcellulose mini-matrices prepared via hot-melt extrusion: in vitro and in vivo evaluation.
Verhoeven E; Vervaet C; Remon JP
Eur J Pharm Biopharm; 2006 Jul; 63(3):320-30. PubMed ID: 16517135
[TBL] [Abstract][Full Text] [Related]
9. Formulation and in-vitro evaluation of floating bilayer tablet of lisinopril maleate and metoprolol tartrate.
Ijaz H; Qureshi J; Danish Z; Zaman M; Abdel-Daim M; Hanif M; Waheed I; Mohammad IS
Pak J Pharm Sci; 2015 Nov; 28(6):2019-25. PubMed ID: 26639495
[TBL] [Abstract][Full Text] [Related]
10. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
11. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
[TBL] [Abstract][Full Text] [Related]
12. Use of natural gums and cellulose derivatives in production of sustained release metoprolol tablets.
Varshosaz J; Tavakoli N; Eram SA
Drug Deliv; 2006; 13(2):113-9. PubMed ID: 16423799
[TBL] [Abstract][Full Text] [Related]
13. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
[TBL] [Abstract][Full Text] [Related]
14. Piecewise function parameters as responses of the design of experiment in the development of a pulsatile release chronopharmaceutical system.
Vonica-Gligor AL; Tomuţă I; Leucuţa SE
Acta Pharm; 2016 Jun; 66(2):173-89. PubMed ID: 27279062
[TBL] [Abstract][Full Text] [Related]
15. Co-extrusion as manufacturing technique for fixed-dose combination mini-matrices.
Dierickx L; Saerens L; Almeida A; De Beer T; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2012 Aug; 81(3):683-9. PubMed ID: 22504402
[TBL] [Abstract][Full Text] [Related]
16. Prilling of fatty acids as a continuous process for the development of controlled release multiparticulate dosage forms.
Vervaeck A; Saerens L; De Geest BG; De Beer T; Carleer R; Adriaensens P; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):587-96. PubMed ID: 23474381
[TBL] [Abstract][Full Text] [Related]
17. Release profile comparison and stability of diltiazem-resin microcapsules in sustained release suspensions.
Junyaprasert VB; Manwiwattanakul G
Int J Pharm; 2008 Mar; 352(1-2):81-91. PubMed ID: 18061381
[TBL] [Abstract][Full Text] [Related]
18. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate.
Allam A; Fetih G
Drug Des Devel Ther; 2016; 10():2421-33. PubMed ID: 27536063
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of different floating tablets containing metronidazole to target stomach.
Loh ZC; Elkordy AA
Curr Drug Deliv; 2015; 12(4):425-43. PubMed ID: 25924732
[TBL] [Abstract][Full Text] [Related]
20. The impact of the injection mold temperature upon polymer crystallization and resulting drug release from immediate and sustained release tablets.
Van Renterghem J; Dhondt H; Verstraete G; De Bruyne M; Vervaet C; De Beer T
Int J Pharm; 2018 Apr; 541(1-2):108-116. PubMed ID: 29409747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
